
Cancer Breakthroughs: Veracyte’s Decipher Tests and GRID Tool at ASCO GU
Cancer Breakthroughs: Veracyte’s Decipher Tests and GRID Tool at ASCO GU Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that new data presented at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) highlight the clinical utility of…












